Amelanotic Melanoma

This is a specific type of melanoma that doesn't have the usual dark color. It's still a form of skin cancer, but it looks different because it lacks melanin. Doctors need to be aware of this type when checking for melanoma.

Condition

What people with Amelanotic Melanoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Keytruda (Pembrolizumab) for Amelanotic Melanoma?

NameHow it went

About Amelanotic Melanoma

What It Is

Amelanotic melanoma is a form of melanoma, the most serious type of skin cancer, in which the cancer cells make little or no pigment. Most melanomas are dark brown or black because they start in melanocytes, the cells that produce the skin's color. In amelanotic melanoma those cells have lost much or all of that ability, so the spot is usually pink, red or skin-colored, sometimes with a faint rim of tan or brown. That lack of color is what makes it matter. Amelanotic melanoma can look like a harmless bump, a patch of irritated skin or a more common skin cancer, and it often does not fit the familiar warning signs for moles. As a result, it tends to be recognized later than pigmented melanoma. It is uncommon, accounting for roughly 2% of melanomas, although estimates vary because many partly pigmented melanomas are also given this label.

Causes & Risk Factors

Like other melanomas, amelanotic melanoma develops when changes in the DNA of melanocytes let them grow out of control. Why some melanomas lose their pigment is not fully understood. The risk factors are largely those of melanoma in general: ultraviolet exposure from sunlight or tanning beds, a history of blistering sunburns, fair skin that freckles or burns easily, red hair, many moles, a personal or family history of melanoma and a weakened immune system. Amelanotic melanoma is somewhat more common in older adults with long-term sun damage and in people with very fair, freckled skin. Having a risk factor does not mean someone will develop melanoma, and melanoma also occurs in people without obvious risk factors, including people with darker skin.

How It's Diagnosed

Diagnosis often begins with a spot that is new, changing, raised or not healing, rather than one that looks like a typical mole. The usual ABCDE checklist (asymmetry, irregular border, uneven color, larger diameter and evolving appearance) relies heavily on dark pigment, so dermatologists also pay close attention to a spot that is red, raised or recently changed. A dermatologist may examine the spot with a dermatoscope, a handheld magnifying light that shows patterns beneath the skin's surface. In amelanotic melanoma the most useful clues are often irregular blood vessel patterns rather than pigment. A full skin exam can add context, such as signs of sun damage or other unusual moles. The diagnosis is confirmed only by removing the spot, or part of it, for examination under a microscope (a biopsy). Because the cells lack pigment, the pathologist may use special stains that identify them as melanocytes. The report also measures the tumor's thickness (Breslow depth, in millimeters), whether the surface is broken down (ulceration) and how quickly the cells are dividing. These features determine the stage, which guides treatment and outlook.

Treatment Options

Amelanotic melanoma is treated the same way as a pigmented melanoma of the same stage. For melanoma confined to the skin, the main treatment is surgery to remove the tumor with a margin of normal skin around it; thicker tumors need wider margins. Because the edges of an unpigmented melanoma can be hard to see, a second surgery is sometimes needed if the first did not remove it completely. For melanomas above a certain thickness, a surgeon may recommend a sentinel lymph node biopsy. This removes the first lymph node or nodes that drain the area to check whether the cancer has begun to spread, which helps decide whether further treatment is worthwhile. When melanoma has spread, or carries a high risk of coming back, treatment may include immunotherapy, which helps the immune system attack the cancer. Common examples are pembrolizumab (Keytruda) and nivolumab (Opdivo). Melanomas with a change in the BRAF gene can also be treated with targeted pills that block the signals driving the cancer's growth. Radiation therapy is used in selected situations. These treatments can control advanced melanoma for long periods in some people, but they do not work for everyone, and immunotherapy can cause the immune system to inflame healthy organs, which requires close monitoring.

What to Expect

Outlook depends mainly on how thick the melanoma is and whether it has spread when it is found. Amelanotic melanomas are, on average, diagnosed at a later stage than pigmented ones, which is the main reason their overall outcomes have looked worse. In a large population study, people with amelanotic and pigmented melanoma of the same stage did about equally well. A thin melanoma removed early is often cured with surgery alone. After treatment, follow-up visits with full skin exams are typically scheduled every few months at first and less often over time, with the frequency depending on stage. Some people with higher-stage disease also have periodic scans. Follow-up matters because melanoma can return, and people who have had one melanoma have a higher chance of developing another. Learning to examine your own skin each month, paying attention to pink or red spots as well as dark ones, and protecting your skin from the sun are lasting parts of life after diagnosis.

When to Seek Help

Arrange a prompt visit with a dermatologist or primary care clinician for any new or changing pink, red or skin-colored spot or bump, especially one that grows over weeks to months, or a spot that bleeds, crusts or does not heal. Bring it up even if it does not look like a mole. If you have been treated for melanoma, contact your care team soon about a new lump near the scar or in the armpit, neck or groin, or any new spot on the skin. People receiving immunotherapy should call their care team promptly about new diarrhea, a rash, shortness of breath or other unexplained symptoms, since early treatment of these side effects matters.

Questions to Ask Your Doctor

  1. 1.What makes you suspect, or rule out, amelanotic melanoma for this spot, and what should the biopsy tell us?
  2. 2.What is the thickness and stage of my melanoma, and what does that mean for my treatment and outlook?
  3. 3.Do I need a sentinel lymph node biopsy or genetic testing of the tumor, and how would the results change my plan?
  4. 4.How often should I have skin checks and other follow-up, and what should I look for on my own skin between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.